Some investors asked Zhenghai Biotech on an interactive platform. How is the company preparing for bone formation protein collection? How to deal with a situation where sales are not growing? On November 12, the company replied that the company closely followed the development of the collection policy, judged and coordinated the layout in advance, and prepared all responses to ensure the smooth and orderly development of production and operation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.